Source: Cells. Unidades: EERP, FCFRP, FMRP
Subjects: ANGIOTENSINAS, INFLAMAÇÃO, VASOPRESSINAS, HIPOTENSÃO, ÓXIDO NÍTRICO, SISTEMA RENINA-ANGIOTENSINA, NEUROPEPTÍDEOS
ABNT
PASSAGLIA, Patrícia et al. Central administration of angiotensin-(1-7) improves vasopressin impairment and hypotensive response in experimental endotoxemia. Cells, v. 10, n. 1, p. 1-16, 2021Tradução . . Disponível em: https://doi.org/10.3390/cells10010105. Acesso em: 17 ago. 2024.APA
Passaglia, P., Faim, F. de L., Batalhão, M. E., Stabile, A. M., Bendhack, L. M., Antunes-Rodrigues, J., et al. (2021). Central administration of angiotensin-(1-7) improves vasopressin impairment and hypotensive response in experimental endotoxemia. Cells, 10( 1), 1-16. doi:10.3390/cells10010105NLM
Passaglia P, Faim F de L, Batalhão ME, Stabile AM, Bendhack LM, Antunes-Rodrigues J, Lacchini R, Cárnio EC. Central administration of angiotensin-(1-7) improves vasopressin impairment and hypotensive response in experimental endotoxemia [Internet]. Cells. 2021 ; 10( 1): 1-16.[citado 2024 ago. 17 ] Available from: https://doi.org/10.3390/cells10010105Vancouver
Passaglia P, Faim F de L, Batalhão ME, Stabile AM, Bendhack LM, Antunes-Rodrigues J, Lacchini R, Cárnio EC. Central administration of angiotensin-(1-7) improves vasopressin impairment and hypotensive response in experimental endotoxemia [Internet]. Cells. 2021 ; 10( 1): 1-16.[citado 2024 ago. 17 ] Available from: https://doi.org/10.3390/cells10010105